MedPath

Comparison of the effects of celiprolol and bisoprolol on central BP and measures of atherosclerosis in hypertensive patients.

Not Applicable
Conditions
Hypertensive patients.
Registration Number
JPRN-UMIN000008913
Lead Sponsor
Jichi Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with malignant hypertension 2.Decompensated heart failure (NYHA III or IV) 3. Malignancy needing treatment 4.Hepatic or renal disease (serum creatinine >3.0mg/dl or under hemodialysis) 5.Those who had had severe side effects with beta blockers 6.Those with contraindication for beta blockers (bronchial asthma, bradycardia, vasospastic angina, pregnant women etc.) 7.Those with hyper- or hypoglycemic attack 8. Those with dementia from whom we cannot obtain informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath